Nivolumab Plus Ipilimumab for Metastatic Castration-Resistant Prostate Cancer: Preliminary Analysis of Patients in the CheckMate 650 Trial
Padmanee Sharma, Russell K. Pachynski, Vivek Narayan, Aude Fléchon, Gwénaëlle Gravis, Matthew D. Galsky, Hakim Mahammedi, Akash Patnaik, Sumit K. Subudhi, Marika Ciprotti, Burçin Şimşek, Abdel Saci, Yanhua Hu, G. Celine Han, Karim Fizazi
Topics & Concepts
IpilimumabNivolumabProstate cancerMedicineOncologyInternal medicineClinical trialCancerImmunotherapyCancer Immunotherapy and BiomarkersProstate Cancer Treatment and ResearchImmunotherapy and Immune Responses